1233749-00-2

Basic information

• Product Name: (S,E)-3-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexanol
• CAS NO: 1233749-00-2
• Molecular Weight: 400.645
• Mol File: 1233749-00-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (S,E)-3-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexanol(CAS DataBase Reference)
• NIST Chemistry Reference: (S,E)-3-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexanol(1233749-00-2)
• EPA Substance Registry System: (S,E)-3-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexanol(1233749-00-2)

Safety Data

• Hazardous Substances Data: 1233749-00-2(Hazardous Substances Data)

Usage

General Description

"(S,E)-3-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexanol is a complex and long chemical compound with multiple functional groups. It contains a cyclohexanol ring, a double bond, and an indene ring. Additionally, it contains a hydroxyl group and a methyl group attached to a heptane chain. (S,E)-3-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexanol's stereochemistry is described as "(S,E)", indicating the configuration of the double bonds. Overall, this chemical appears to be a highly specific and intricate molecule with potentially complex biological and chemical properties."

Upstream product

• 87417-12-7 (3-bromo-1,1-dimethylpropoxy)triethylsilane 
• 87407-65-6 3β-<(triethylsilyl)oxy>-20(S)-<<(p-tolylsulfonyl)oxy>-methyl>-9,10-secopregna-5(E),7(E),10(19)-triene 
• 170081-45-5 3(S)-<(tert-butyldimethylsilyl)oxy>-20(S)-(iodomethyl)-9,10-secopregna-5(E),7(E),10(19)-triene 
• 140710-90-3 25-hydroxy-5E-[6,19,19'-H3]vitamin D3-3β-tert-butyldimethylsilyl ether 
• 104973-32-2 6(S),19-(N,N'-phthalhydrazido)-3β-acetoxy-25-hydroxy-9,10-secocholesta-5(10),7(E),22(Z)-triene 
• 87417-00-3 6(S),19-(N,N'-phthalhydrazido)-3β-acetoxy-9,10-secoergosta-5(10),7(E),22(E)-triene 
• 87417-16-1 C₂₉H₄₀OPSi⁽¹⁺⁾*C₂₄H₂₀B^(1-) 
• 104875-13-0 Acetic acid (2S,14S)-14-[(1R,3aS,7aR)-1-((Z)-(R)-1,5-dimethyl-5-triethylsilanyloxy-hex-2-enyl)-7a-methyl-octahydro-inden-(4E)-ylidenemethyl]-7,12-dioxo-1,2,3,4,5,7,12,14-octahydro-phthalazino[2,3-b]phthalazin-2-yl ester 
• 104849-51-6 Toluene-4-sulfonic acid (S)-2-{(1R,3aS,7aR)-4-[1-(2,2-dioxo-6-triethylsilanyloxy-2,3,4,5,6,7-hexahydro-1H-2λ⁶-benzo[c]thiophen-1-yl)-meth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-propyl ester 
• 104973-29-7 6(S),19-(N,N'-phthalhydrazido)-3β-acetoxy-20(S)-formyl-9,10-secopregna-5(10),7(E)-diene 
• 87680-61-3 Triethyl-{(S)-3-[(1R,3aS,7aR)-7a-methyl-1-((E)-(1R,4R)-1,4,5-trimethyl-hex-2-enyl)-octahydro-inden-(4E)-ylidenemethyl]-2,2-dioxo-2,3,4,5,6,7-hexahydro-1H-2λ⁶-benzo[c]thiophen-5-yloxy}-silane 
• 87680-62-4 (S)-2-{(1R,3aS,7aR)-4-[1-((S)-2,2-Dioxo-6-triethylsilanyloxy-2,3,4,5,6,7-hexahydro-1H-2λ⁶-benzo[c]thiophen-1-yl)-meth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-propionaldehyde 
• 87407-50-9 (S)-2-{(1R,7aR)-4-[1-((S)-2,2-Dioxo-6-triethylsilanyloxy-2,3,4,5,6,7-hexahydro-1H-2λ⁶-benzo[c]thiophen-1-yl)-meth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-propan-1-ol 
• 87407-52-1 3β-<(triethylsilyl)oxy>-20(S)-(hydroxymethyl)-9,10-secopregna-5(E),7(E),10(19)-triene 

Downstream Products

• 87417-20-7 3,5-Dinitro-benzoic acid (S)-3-[2-[(1R,3aS,7aR)-1-((R)-5-hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-(4E)-ylidene]-eth-(E)-ylidene]-4-methylene-cyclohexyl ester 
• 19356-17-3 calcidiol 

Relevant articles and documents

Preparation method of 25-hydroxyvitamin D3, 1alpha, 25-dihydroxyvitamin D3 and isotope internal standard compound thereof

The invention discloses a preparation method of 25-hydroxyvitamin D3 and 1alpha, 25-dihydroxyvitamin D3 and an isotope internal standard compound thereof. The preparation method comprises the following steps: a compound III is subjected to SO2 conjugate protection, O3 oxidation, NaBH4 reduction, iodination ring opening, conjugate addition with acrylate, and reaction with a methyl Grignard reagentor isotope labeled methyl Grignard reagent, a silicon protecting group is removed under the action of TBAF, and a product is obtained through ultraviolet irradiation configuration inversion under thecatalysis of 9-acetyl anthracene. The method is good in reaction selectivity, high in total yield, simple and convenient to operate and short in isotope introduction step, and the isotope utilizationrate is greatly increased.